Societe de Promotion Pharmaceutique du Maghreb S.A. (CBSE:PRO)
1,300.00
0.00 (0.00%)
At close: Aug 7, 2026
Societe de Promotion Pharmaceutique du Maghreb Company Description
Societe de Promotion Pharmaceutique du Maghreb S.A. manufactures and markets pharmaceutical and dermo-cosmetic products in the United States, Canada, and internationally.
It provides its products for therapeutic areas, including respiratory, oncology, and pain management.
It also offers injectable, and oral and respiratory manufacturing capabilities. The company was founded in 1947 and is based in Casablanca, Morocco.
Societe de Promotion Pharmaceutique du Maghreb S.A. is a subsidiary of Hikma Pharmaceuticals PLC.
Societe de Promotion Pharmaceutique du Maghreb S.A.
| Country | Morocco |
| Founded | 1947 |
| Industry | Pharmaceutical Preparations |
| Employees | 343 |
| CEO | Salameh Al Araideh |
Contact Details
Address: Street 7 - Sahel Industrial Zone Casablanca, 26 400 Morocco | |
| Website | hikma.com |
Stock Details
| Ticker Symbol | PRO |
| Exchange | Casablanca Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | MAD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Salameh Al Araideh | Chief Executive Officer |
| Hassane Zioud | Chief Financial Officer |